Butylscopolamine Bromide Market

Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.

Butylscopolamine Bromide Market contains market size and forecasts of Butylscopolamine Bromide in Global, including the following market information:

Global Butylscopolamine Bromide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Butylscopolamine Bromide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Butylscopolamine Bromide include Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical and Jiangsu Ange Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Butylscopolamine Bromide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Butylscopolamine Bromide Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Butylscopolamine Bromide Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Intramuscular Injection

Intravenous Or Drip

Suppositories

Other

Global Butylscopolamine Bromide Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Butylscopolamine Bromide Market Segment Percentages, by Application, 2021 (%)

Stomach

Gas Barium Hypography

Abdominal CT Scan

Gastrointestinal Spasm

Biliary Colic

Renal Colic

Gastrointestinal Hypermotility

Other

Global Butylscopolamine Bromide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Butylscopolamine Bromide Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Butylscopolamine Bromide revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Butylscopolamine Bromide revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

Boehringer Ingelheim

Sandoz (Novartis)

Boehringer Ingelheim Pharma GmbH & Co. KG

XI AN TIANXINGJIAN PHARMCHEM

Linnea

Alkaloida

Chengdu Tiantaishan Pharmaceutical

Jiangsu Ange Pharmaceutical

Chengdu First Pharmaceutical

Beijing Zizhu Pharmaceutical

Guangdong Zhongsheng Pharmaceutical

Wanbangde Pharmaceutical Group

Shandong Yijian Pharmaceutical